MENU
+Compare
FMCQF
Stock ticker: OTC
AS OF
Aug 29 closing price
Price
$52.47
Change
+$1.47 (+2.88%)
Capitalization
14.96B

FMCQF stock forecast, quote, news & analysis

Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024... Show more

FMCQF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for FMCQF with price predictions
Aug 29, 2025

FMCQF's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for FMCQF turned positive on August 11, 2025. Looking at past instances where FMCQF's MACD turned positive, the stock continued to rise in of 34 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 41 cases where FMCQF's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 29, 2025. You may want to consider a long position or call options on FMCQF as a result. In of 47 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

FMCQF broke above its upper Bollinger Band on August 29, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for FMCQF entered a downward trend on August 28, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.996) is normal, around the industry mean (9.579). P/E Ratio (20.203) is within average values for comparable stocks, (117.052). Projected Growth (PEG Ratio) (0.439) is also within normal values, averaging (2.114). Dividend Yield (0.031) settles around the average of (0.039) among similar stocks. P/S Ratio (0.677) is also within normal values, averaging (1.595).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. FMCQF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FMCQF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.

A.I.Advisor
published Dividends

FMCQF paid dividends on May 26, 2021

Fresenius Medical Care AG FMCQF Stock Dividends
А dividend of $1.34 per share was paid with a record date of May 26, 2021, and an ex-dividend date of May 21, 2021. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are DaVita (NYSE:DVA), Community Health Systems (NYSE:CYH).

Industry description

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

Market Cap

The average market capitalization across the Hospital/Nursing Management Industry is 4.04B. The market cap for tickers in the group ranges from 48.5K to 94.52B. HCA holds the highest valuation in this group at 94.52B. The lowest valued company is BYZN at 48.5K.

High and low price notable news

The average weekly price growth across all stocks in the Hospital/Nursing Management Industry was -2%. For the same Industry, the average monthly price growth was 4%, and the average quarterly price growth was 6%. NUMIF experienced the highest price growth at 45%, while MODV experienced the biggest fall at -60%.

Volume

The average weekly volume growth across all stocks in the Hospital/Nursing Management Industry was -63%. For the same stocks of the Industry, the average monthly volume growth was 251% and the average quarterly volume growth was 110%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 65
Price Growth Rating: 58
SMR Rating: 77
Profit Risk Rating: 85
Seasonality Score: -16 (-100 ... +100)
View a ticker or compare two or three
FMCQF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry HospitalNursingManagement

Profile
Fundamentals
Details
Industry
N/A
Address
Else-Kroener-Strasse 1
Phone
+49 791033353
Employees
119845
Web
https://www.freseniusmedicalcare.com